{"id":"W2060432974","doi":"10.1038/pcan.2013.2","title":"Phase III, randomized, placebo-controlled study of once-daily oral zibotentan (ZD4054) in patients with non-metastatic castration-resistant prostate cancer","year":2013,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"AstraZeneca","keywords":"Medicine; Placebo; Prostate cancer; Hazard ratio; Internal medicine; Interim analysis; Adverse effect; Randomized controlled trial; Confidence interval; Oncology; Cancer; Urology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001198108,0.001736039,0.003631363,0.0004965767,0.0005773013,0.0010637,0.001288441,0.001330134,0.006109555],"category_scores_gemma":[0.00101269,0.000957278,0.001354711,0.0005013083,0.001438788,0.0009272171,0.0004003986,0.003267878,0.0009935034],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009273425,"about_ca_system_score_gemma":0.001679045,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002566883,"about_ca_topic_score_gemma":0.004989496,"domain_scores_codex":[0.9996153,0.0001554064,0.00001841155,0.00007187965,0.00003613164,0.0001028212],"domain_scores_gemma":[0.9993036,0.0001359117,0.0001188677,0.00005778992,0.00004243934,0.0003414257],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9664497,0.01401292,0.0007132305,0.0003346551,0.0007164479,0.00003352447,0.00005272375,0.0003812363,0.006009117,0.00009463685,0.0005422286,0.01065946],"study_design_scores_gemma":[0.9285086,0.06827249,0.001941288,0.000007363373,0.0002342117,0.00001966375,0.00002186959,0.0002705005,0.0003744847,0.00005362654,0.0002861,0.000009886545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918813,0.001545144,0.0006721655,0.0004119404,0.0003614716,0.002817866,0.0008392151,0.0001380103,0.001332891],"genre_scores_gemma":[0.9885056,0.001756046,0.001267069,0.0008446943,0.0002981275,0.002708767,0.001183536,0.00002950683,0.003406599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006109555,"threshold_uncertainty_score":0.02043855,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008647926792209042,"score_gpt":0.2850561213410108,"score_spread":0.2764081945488018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}